Viewing Study NCT02674269


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-05 @ 6:31 PM
Study NCT ID: NCT02674269
Status: WITHDRAWN
Last Update Posted: 2017-06-16
First Post: 2016-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")
Sponsor: UroGen Pharma Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-10
Start Date Type: ESTIMATED
Primary Completion Date: 2016-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2016-10
Completion Date Type: ESTIMATED
First Submit Date: 2016-02-01
First Submit QC Date: None
Study First Post Date: 2016-02-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-06-15
Last Update Post Date: 2017-06-16
Last Update Post Date Type: ACTUAL